Skip to main content
logo
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9967
+0.0617 (6.60%)
Aug 26, 2026, 4:00 PM EDT - Market closed

CytoMed Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
12153956--
Market Cap Growth
-48.19%-60.73%-30.55%---
Enterprise Value
11143549--
Last Close Price
1.001.333.404.90--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.6223.02106.38146.86--
PB Ratio
2.322.895.926.63--
P/TBV Ratio
2.363.096.046.64--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.7520.3393.59127.72--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.070.050.047.201.26
Net Debt / Equity Ratio
-0.23-0.23-0.50-0.764.500.28
Net Debt / EBITDA Ratio
0.420.421.612.47-1.80-0.52
Net Debt / FCF Ratio
0.370.371.102.38-1.41-0.32
Asset Turnover
0.100.100.050.060.060.02
Inventory Turnover
0.090.090.040.010.020.01
Quick Ratio
3.143.148.3912.830.390.86
Current Ratio
5.175.179.8914.080.601.12
Return on Equity (ROE)
-50.28%-50.28%-24.86%-69.87%-197.08%-133.79%
Return on Assets (ROA)
-29.31%-29.31%-17.44%-27.30%-20.55%-21.98%
Return on Capital Employed (ROCE)
-58.20%-58.20%-33.10%-33.00%-175.10%-55.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-26.24%-20.09%-4.70%-5.54%--
FCF Yield
-28.91%-21.88%-7.68%-4.81%--
Buyback Yield / Dilution
-0.93%-0.93%-8.56%-34.30%-14.14%-17.59%
SEC Filings: 10-K · 10-Q